GAMMA Investing’s Organogenesis Holdings ORGO Stock Holding History

GAMMA Investing’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30	Closed	-$155	–	4203
2025 Q4	$155	Sell	30 -30	-50%	-$145	﹤0.01%	4026
2025 Q3	$253	Buy	+60	New	+$279	﹤0.01%	3789
2025 Q2	–	Sell	-238	Closed	-$1.03K	–	3864
2025 Q1	$1.03K	Buy	+238	New	+$961	﹤0.01%	3554

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

GAMMA Investing's ORGO Position: Q1 2026 in Review

GAMMA Investing sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 30 shares — an estimated $155 sold.

GAMMA Investing first reported a position in ORGO in Q1 2025 and held it in 3 quarters. The position peaked at $1.03K in Q1 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

GAMMA Investing reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
GAMMA Investing sold 30 Organogenesis Holdings shares in Q1 2026, an estimated $155.
GAMMA Investing first reported a position in Organogenesis Holdings in Q1 2025 and held it in 3 quarters.
GAMMA Investing's Organogenesis Holdings position peaked at $1.03K in Q1 2025.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on GAMMA Investing's 13F filing for Q1 2026, filed 6 Apr 2026.